• Markets
    • icon
  • Companies
NYR · ASX

Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (ASX:NYR)

AU$0.02

 0.0 (0.0%)
ASX:Live
05/12/2023 02:21:09 PM
HALO Ords GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

NYR Overview

NYR Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About NYR

Website

Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs

Telephone

N/A

Address

Description

N/A

NYR Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

-4.76%

1 month

-4.76%

YTD

-86.21%

1 year

-84%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Healthcare

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

NYR Announcements

Latest Announcements

Date Announcements

30 March 22

Investor Roadshow Presentation

×

Investor Roadshow Presentation

30 January 23

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

30 August 21

Annual Report to 30 June 2021

×

Annual Report to 30 June 2021

30 April 20

Nyrada Preclinical Program & Corporate Update Presentation

×

Nyrada Preclinical Program & Corporate Update Presentation

29 September 22

Presentation to ShareCafe Hidden Gems Webinar

×

Presentation to ShareCafe Hidden Gems Webinar

29 March 22

New Drug Offers Potential Oral Treatment for Concussion

×

New Drug Offers Potential Oral Treatment for Concussion

29 June 22

Cholesterol-Lowering Program Update

×

Cholesterol-Lowering Program Update

29 August 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 August 22

Preliminary Final Report

×

Preliminary Final Report

29 August 22

Annual Report to June 30 2022

×

Annual Report to June 30 2022

29 August 22

Nyrada Reports Full Year FY2022 Results

×

Nyrada Reports Full Year FY2022 Results

28 July 23

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

28 August 23

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

28 August 23

Preliminary Final Report

×

Preliminary Final Report

28 August 23

Annual Report for year ended 30 June 2023

×

Annual Report for year ended 30 June 2023

28 August 23

Full Year Results FY2023

×

Full Year Results FY2023

27 October 22

CEO Remuneration Update

×

CEO Remuneration Update

27 February 20

Nyrada Inc. Corporate Presentation February 2020

×

Nyrada Inc. Corporate Presentation February 2020

26 October 22

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

26 May 23

Cholesterol-Lowering Program Preclinical Studies Completed

×

Cholesterol-Lowering Program Preclinical Studies Completed

26 June 23

Cholesterol-Lowering Program Update

×

Cholesterol-Lowering Program Update

26 July 22

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

26 April 23

Quarterly Activities Report and Appendix 4C

×

Quarterly Activities Report and Appendix 4C

25 February 22

Appendix 4D and Half Year Report to 31 December 2021

×

Appendix 4D and Half Year Report to 31 December 2021

25 February 22

Nyrada Half Year Results FY2022

×

Nyrada Half Year Results FY2022

24 June 20

Corporate Presentation for the Reach Markets Virtual Event

×

Corporate Presentation for the Reach Markets Virtual Event

24 February 23

Appendix 4D and Half Year Report to 31 December 2022

×

Appendix 4D and Half Year Report to 31 December 2022

24 February 23

Nyrada Half Year Results FY2023

×

Nyrada Half Year Results FY2023

NYR Fundamentals

Per Share Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.03 -0.03 -0.05 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.03 -0.03 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 42.8 15.6 -96.5 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.02 -0.02 -0.05 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.02 -0.02 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 50.6 -24.1 -142.3 Lock Lock Lock
     Yield % Lock Lock Lock Lock -7.4 -14.0 -165.5 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.09 0.07 0.03 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.09 0.07 0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock 84.6 -20.7 -63.1 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 117 156 156 Lock Lock Lock
Basic m Lock Lock Lock Lock 117 156 156 Lock Lock Lock

Financial Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 6 5 9 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -21.6 -163.3 -38.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -6 -5 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.3 13.3 -88.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -6 -5 -9 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.3 13.2 -88.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -4 -5 -9 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 -1 -1 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -4 -4 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock 38.9 -12.7 -96.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -3 -3 -7 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 11 0 0 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -3 -3 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 37.3 -6.2 -146.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 14 11 4 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 15 12 5 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -14 -11 -4 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 1 1 1 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 14 11 4 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 14 11 4 Lock Lock Lock
     Growth % Lock Lock Lock Lock 162.2 -20.7 -63.0 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -23.3 -33.1 -151.3 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -24.3 -34.6 -183.5 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -56.0 -37.4 -116.1 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -35.2 -30.6 -99.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -27.6 -22.6 -91.8 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.5 2.2 0.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -94.9 -94.1 -87.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 22.7 25.4 5.8 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 22.7 25.4 5.8 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 91.0 90.4 72.3 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -415.2 -621.4 -817.9 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -23.3 -33.1 -151.3 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.0 1.0 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -24.3 -34.6 -183.5 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -24.3 -34.6 -183.5 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 29,918.0 5,858.7 15,869.6 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -29,918.0 -5,858.7 -15,869.6 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

NYR Shortsell

Frequently Asked Questions

The current share price of Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is AU$0.02.
The 52-week high share price for Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is AU$0.00.
The 52-week low share price for Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX)? is AU$0.00.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not pay a dividend.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not pay a dividend.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) does not offer franking credits.
Nyrada, Inc. Shs Chess Depository Interests Repr 1 Shs (NYR:ASX) is classified in the Healthcare.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.